Rigel Pharmaceuticals Inc Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.75M125.00M4.75M2.25M7.15M8.25M28.89M20.38M44.51M59.29M108.62M149.24M120.24M116.88M179.28M
Cost of Revenue 0.29M0.91M0.90M1.08M1.75M7.11M18.65M
Gross Profit 0.75M125.00M4.75M2.25M7.15M8.25M28.89M20.38M44.22M58.38M107.73M148.15M118.49M109.77M160.63M
Operating items
Research & Development 90.74M64.39M69.35M78.78M75.33M67.70M62.83M63.45M46.27M46.90M52.88M60.10M65.24M60.27M24.52M23.38M
Selling, General & Administrative 20.90M25.29M21.77M22.85M19.61M22.50M17.81M20.91M37.83M70.00M74.59M76.60M91.89M112.45M105.74M113.06M
Restructuring Costs 1.14M1.68M5.77M3.52M1.32M
Other Operating Expenses 0.02M0.02M0.10M0.06M0.09M0.73M0.29M0.91M0.90M1.08M1.75M7.11M18.65M
Operating Expenses 112.79M89.68M91.12M101.63M96.62M99.50M80.64M90.12M84.10M117.19M128.38M137.59M161.73M175.79M137.37M155.09M
Operating Income -112.04M35.32M-86.37M-99.38M-89.47M-91.25M-51.74M-69.74M-79.62M-72.68M-69.09M-28.97M-12.50M-55.55M-20.49M24.19M
EBIT -112.04M35.32M-86.37M-99.38M-89.47M-91.25M-51.74M-69.74M-79.62M-72.68M-69.09M-28.97M-12.50M-55.55M-20.49M24.19M
Non-operating items
Interest & Investment Income 0.60M0.30M0.42M0.52M0.43M0.24M0.22M0.44M0.89M2.20M2.53M0.58M0.05M0.68M2.27M2.09M
Other Non Operating Income 140.74M2.36M
Net income details
EBT -111.64M37.89M-85.97M-98.86M-89.04M-91.01M-51.52M-69.30M-78.72M-70.48M-66.89M-29.74M-17.31M-58.57M-25.09M18.37M
Tax Provisions -0.09M0.60M0.90M
Profit After Tax 111.55M37.89M-85.97M-98.86M-89.04M-91.01M-51.52M-69.30M-78.72M-70.48M-66.89M-29.74M-17.91M-58.57M-25.09M17.48M
Income from Continuing Operations -111.55M37.89M-85.97M-98.86M-89.04M-91.01M-51.52M-69.30M-78.72M-70.48M-66.89M-29.74M-17.91M-58.57M-25.09M17.47M
Consolidated Net Income -111.55M37.89M-85.97M-98.86M-89.04M-91.01M-51.52M-69.30M-78.72M-70.48M-66.89M-29.74M-17.91M-58.57M-25.09M17.47M
Income towards Parent Company -111.55M37.89M-85.97M-98.86M-89.04M-91.01M-51.52M-69.30M-78.72M-70.48M-66.89M-29.74M-17.91M-58.57M-25.09M17.47M
Net Income towards Common Stockholders -111.55M37.89M-85.97M-98.84M-89.03M-90.91M-51.46M-69.22M-77.99M-70.48M-66.89M-29.74M-17.91M-58.57M-25.09M17.47M
Additional items
EPS (Basic) -0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 5.18M5.21M7.12M8.70M8.74M8.78M8.85M9.89M14.65M16.66M16.76M16.90M17.10M17.28M17.44M17.62M
Shares Outstanding (Diluted Average) 40.88M52.57M63.33M167.40M168.75M170.49M17.05M17.40M17.69M
EBITDA -112.04M35.32M-86.37M-99.38M-89.47M-91.25M-51.74M-69.74M-79.62M-72.68M-69.09M-28.97M-12.50M-55.55M-20.49M24.19M
Tax Rate 0.08%4.90%